EcoDrugPlus

Calcium Channel, Voltage-Dependent, Alpha 2/delta Subunit 4a

Ensembl ID : ENSDARG00000026855
Gene Symbol: CACNA2D4A
4 Enzyme and pathways 5 Cross references
232 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Alpha 2/delta Subunit 4b

Ensembl ID : ENSDARG00000023886
Gene Symbol: CACNA2D4B
5 Cross references
233 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 1 Subunit

Ensembl ID : ENSDARG00000002167
Gene Symbol: CACNB1
7 Enzyme and pathways 5 Cross references
210 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 2a

Ensembl ID : ENSDARG00000099045
Gene Symbol: CACNB2A
10 Enzyme and pathways 5 Cross references
204 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 3a

Ensembl ID : ENSDARG00000001881
Gene Symbol: CACNB3A
10 Enzyme and pathways 5 Cross references
203 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 3b

Ensembl ID : ENSDARG00000076030
Gene Symbol: CACNB3B
5 Cross references
208 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Beta 4a Subunit

Ensembl ID : ENSDARG00000009738
Gene Symbol: CACNB4A
7 Enzyme and pathways 5 Cross references
164 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 1a

Ensembl ID : ENSDARG00000008772
Gene Symbol: CACNG1A
5 Cross references
196 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 1b

Ensembl ID : ENSDARG00000052360
Gene Symbol: CACNG1B
4 Enzyme and pathways 5 Cross references
197 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 2a

Ensembl ID : ENSDARG00000032565
Gene Symbol: CACNG2A
9 Enzyme and pathways 5 Cross references
249 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 2b

Ensembl ID : ENSDARG00000102376
Gene Symbol: CACNG2B
5 Cross references
249 Possible Orthologues:

Calcium Channel, Voltage-Dependent, Gamma Subunit 3a

Ensembl ID : ENSDARG00000058460
Gene Symbol: CACNG3A
5 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).